Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-07

Clinical Trial Update: Effects of Escitalopram on Autonomic Reactivity in Post Traumatic Stress Disorder [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of escitalopram on autonomic reactivity in post-traumatic stress disorder has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Escitalopram (escitalopram)

Snippet

Sponsor: VA Nebraska Western Iowa Health Care System | Conditions: PTSD | Phase 4 | Status: COMPLETED | Results posted: 2014-10-07